Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

被引：0

作者：

Trauth, Janina ^{[1
]}

Schuler, Rahel ^{[2
]}

Waitz, Markus ^{[2
]}

Ehrhardt, Harald ^{[2
,4
]}

Fritzenwanker, Moritz ^{[3
]}

Herold, Susanne ^{[1
]}

机构：

[1] Justus Liebig Univ, Dept Med Internal Med Infect Dis & Infect Control, Giessen, Germany

[2] Justus Liebig Univ, Dept Gen Pediat & Neonatol, Giessen, Germany

[3] Justus Liebig Univ Giessen, Inst Med Microbiol, Giessen, Germany

[4] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Intens Care Med, Ulm, Germany

来源：

INFECTION | 2024年

关键词：

Multi drug resistance; Stenotrophomonas maltophilia; Cefiderocol; Pneumogenic sepsis; Neonate;

D O I：

10.1007/s15010-024-02404-9

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Cefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.

引用

页数：4

共 50 条

[1] Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol (OCT, 10.1007/s15010-024-02404-9, 2024)
Trauth, Janina
Schuler, Rahel
Waitz, Markus
Ehrhardt, Harald
Fritzenwanker, Moritz
Herold, Susanne
INFECTION, 2025,
[2] Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
Hsu, Alice J.
Simner, Patricia J.
Bergman, Yehudit
Mathers, Amy J.
Tamma, Pranita D.
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
[3] Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
Petraitis, Vidmantas
Petraitiene, Ruta
Kavaliauskas, Povilas
Naing, Ethan
Garcia, Andrew
Ishibashi, Naoki
Georgiades, Benjamin
Echols, Roger
Bonomo, Robert A.
Yamano, Yoshinori
Satlin, Michael J.
Walsha, Thomas J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (10)
[4] Suitable empiric antibiotic therapy saves lives in nosocomial pneumonia caused by Stenotrophomonas maltophilia
Yilmaz, Guerdal
Ozsu, Savas
Koksal, Iftihar
Ozlu, Tevfik
TURKISH JOURNAL OF MEDICAL SCIENCES, 2010, 40 (01) : 99 - 103
[5] Stenotrophomonas maltophilia as a Pathogen of Nosocomial Pneumonia: Seven Case Reports
Ozdemir, Levent
Ozdemir, Burcu
Havlucu, Yavuz
TURKISH THORACIC JOURNAL, 2013, 14 (02) : 72 - 74
[6] Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia
Tseng, Chia-Cheng
Fang, Wen-Feng
Huang, Kuo-Tung
Chang, Pei-Wen
Tu, Mei-Lien
Shiang, Yi-Ping
Douglas, I. S.
Lin, Meng-Chih
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (12): : 1193 - 1202
[7] Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy
Emanuela Zappulo
Francesco Grimaldi
Rossella Paolillo
Biagio Pinchera
Antonio Riccardo Buonomo
Marco Picardi
Maria Rosaria Catania
Fabrizio Pane
Ivan Gentile
Annals of Hematology, 2022, 101 : 2805 - 2806
[8] Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy
Zappulo, Emanuela
Grimaldi, Francesco
Paolillo, Rossella
Pinchera, Biagio
Buonomo, Antonio Riccardo
Picardi, Marco
Catania, Maria Rosaria
Pane, Fabrizio
Gentile, Ivan
ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2805 - 2806
[9] Stenotrophomonas maltophilia as a nosocomial pathogen
Köseoglu, Ö
Sener, B
Gülmez, D
Altun, B
Gür, D
MICROBIOLOGICA, 2004, 27 (03): : 273 - 279
[10] Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia.
Fang, W. F.
Tseng, C. C.
Huang, K. T.
Chang, P. W.
Douglas, I. S.
Lin, M. C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179

← 1 2 3 4 5 →